drugset / Trial / NCT01228630

Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.

NCT01228630

Phase 3 Completed 156 enrolled Azidus Brasil EMS S/A · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The loratadine-pseudoephedrine combination has proven to be more effective than the use of these individual components. This prospective, randomized, double-blind and paralel study, in which patients with perennial allergic rhinitis receive one of loratadine + pseudoephedrine association drug for treatment of signs and symptoms during 4 weeks.

Timeline

Start
2011-08
Primary completion
2012-04
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Background Loratadine Small molecule 5 mg
Background Pseudoephedrine Small molecule 120 mg